Patient Perceptions and Potential Utility of Pharmacogenetic Testing in Chronic Pain Management and Opioid Use Disorder in the Camden Opioid Research Initiative

Pharmacogenetics (PGx) has the potential to improve opioid medication management. Here, we present patient perception data, pharmacogenetic data and medication management trends in patients with chronic pain (arm 1) and opioid use disorder (arm 2) treated at Cooper University Health Care in Camden C...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Dara Kusic, Jessica Heil, Stefan Zajic, Andrew Brangan, Oluseun Dairo, Gretchen Smith, Diego Morales-Scheihing, Russell J. Buono, Thomas N. Ferraro, Rachel Haroz, Matthew Salzman, Kaitlan Baston, Elliot Bodofsky, Michael Sabia, Alissa Resch, Laura B. Scheinfeldt
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2022-09-01
Saila:	Pharmaceutics
Gaiak:	pharmacogenetic opioid chronic pain OUD
Sarrera elektronikoa:	https://www.mdpi.com/1999-4923/14/9/1863
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!